Events/Webinars
Empoderar a los farmacéuticos para apoyar la deshabituación tabáquica en la región de las Américas
11 July 2024En la Región de las Américas, el 16,6% de las personas mayores de 15 años son consumidores de tabaco. Dada la prevalencia y carga global y regional del consumo de tabaco, particularmente como factor de riesgo de enfermedades no transmisibles, es importante que se amplíe y consolide el papel de los farmacéuticos en la prevención y la deshabituación del consumo de tabaco.
La FIP y su Foro Farmacéutico de las Américas le invitan a participar en este evento para conocer la carga del consumo de tabaco en la región de las Américas y el papel que pueden desempeñar los farmacéuticos en la deshabituación tabáquica. El evento incluirá reflexiones de la OPS, ejemplos de servicios farmacéuticos en los países y la presentación de los recursos de la FIP para avanzar en la deshabituación tabáquica a través de los farmacéuticos.
Empowering pharmacists to support tobacco cessation in Europe
8 July 2024In the European Region, 25.3% of people aged 15 years and over were current tobacco users. Given the global and regional prevalence and burden of tobacco use, particularly as a risk factor for noncommunicable diseases, it is important that the role of pharmacists in this area is expanded and consolidated.
FIP you to join this event to learn more about the burden of tobacco use in Europe and the role that pharmacists can play in tobacco cessation. The event will include insights from the WHO Regional Office, country examples of pharmacist services and the presentation of FIP resources to advance tobacco cessation through pharmacists.
Empowering pharmacists to support tobacco cessation in Africa
3 July 2024In the African Region, 9.5% of people aged 15 years and over were current tobacco users. Given the global and regional prevalence and burden of tobacco use, particularly as a risk factor for noncommunicable diseases, it is important that the role of pharmacists in this area is expanded and consolidated.
FIP and the African Pharmaceutical Forum invite you to join this event to learn more about the burden of tobacco use in the African region and the role that pharmacists can play in tobacco cessation.
Empowering pharmacists to support tobacco cessation in the Eastern Mediterranean Region
2 July 2024In the Eastern Mediterranean Region, 17.9 % of people aged 15 years and over are tobacco users. Given the global and regional prevalence and burden of tobacco use, particularly as a risk factor for noncommunicable diseases, it is important that the role of pharmacists in tobacco use prevention and cessation is expanded and consolidated.
FIP and the Eastern Mediterranean Regional Pharmaceutical Forum invite you to join this event to learn more about the burden of tobacco use in the Eastern Mediterranean region and the role that pharmacists can play in tobacco cessation. The event includes insights from the WHO Regional Office, country examples of pharmacist services and the presentation of FIP resources to advance tobacco cessation through pharmacists.
Empowering pharmacists to support tobacco cessation in Southeast Asia
27 June 2024In the South-East Asia Region, 26.5% of people aged 15 years and over were current tobacco users. Given the global and regional prevalence and burden of tobacco use, particularly as a risk factor for noncommunicable diseases, it is important that the role of pharmacists in this area is expanded and consolidated.
FIP and the SEARPharm Forum invite you to join this event to learn more about the burden of tobacco use in the South-East Asia region and the role that pharmacists can play in tobacco cessation. The event includes insights from the WHO Regional Office, country examples of pharmacist services and the presentation of FIP resources to advance tobacco cessation through pharmacists.
Empowering pharmacists to support tobacco cessation in Western Pacific Region
25 June 2024In the Western Pacific Region, 22.5 % of people aged 15 years and over were current tobacco users. Given the global and regional prevalence and burden of tobacco use, particularly as a risk factor for noncommunicable diseases, it is important that the role of pharmacists in this area is expanded and consolidated.
FIP and the Western Pacific Pharmaceutical Forum invite you to join this event to learn more about the burden of tobacco use in the Western Pacific region and the role that pharmacists can play in tobacco cessation. The event will include insights from the WHO Regional Office, country examples of pharmacist services and the presentation of FIP resources to advance tobacco cessation through pharmacists.
Leveraging pharmacists for tobacco cessation: New policy tools, evidence, and success stories
31 May 2024There are 1.25 billion adult tobacco users around the world, and 60% of them want to quit, but only around 35% of the world’s population have access to comprehensive tobacco cessation services.
Given the global prevalence and burden of tobacco use, particularly as a risk factor for noncommunicable diseases, it is important that the services provided by pharmacists in this area are expanded and consolidated. At this event, FIP will launch a global intelligence report on pharmacist-led tobacco cessation services. A joint WHO-FIP statement and call to action on the role of pharmacists in tobacco cessation and examples of successful pharmacist interventions/services in tobacco cessation will also be presented, along with findings from a survey and a systematic literature review.
Leveraging the role of pharmacists in tobacco cessation in India
10 August 2023Tobacco use is a global health problem with 1.13 billion smokers and 8 million deaths annually, including 1.2 million from second-hand smoke. With a smoking prevalence of 27.
2%, India is the thirty-seventh country with the highest smoking prevalence. It is a burden on individuals, communities and economies, causing various diseases and preventable deaths. Tobacco is a major risk factor for non-communicable diseases such as chronic respiratory and cardiovascular diseases, cancer and diabetes.
This digital event was organised by the Indian Pharmaceutical Association (IPA) in collaboration with the International Pharmaceutical Federation (FIP) and the World Health Organisation (WHO). During the webinar, the FIP presented the two new publications on tobacco cessation: “Supporting tobacco cessation and the treatment of tobacco dependence: A handbook for pharmacists” and the “Knowledge and skills reference guide for professional development in tobacco cessation and other risk factors in NCDs”.
Leveraging the role of pharmacists in tobacco cessation in Jordan
3 August 2023Tobacco use is a global health problem with 1.13 billion smokers and 8 million deaths annually, including 1.2 million from second-hand smoke. Jordan ranks as the fourteenth country globally with the highest rate of smokers, which represent 34.
8% of the population.1 It is a burden on individuals, communities and economies, causing various diseases and preventable deaths. Tobacco is a major risk factor for non-communicable diseases such as chronic respiratory and cardiovascular diseases, cancer and diabetes. At this event, FIP will present a new handbook to support pharmacists and their organizations in providing a range of tobacco cessation services. This will be accompanied by a reference guide identifying the knowledge and skills pharmacists need to provide such services.
This event was organised by Jordan Pharmacists Association (JPA) in collaboration with International Pharmaceutical Federation (FIP) and World Health Organization (WHO).
1 Data from: Smoking Rates by Country. https://wisevoter.com/country-rankings/smoking-rates-by-country/#jordan
The role of pharmacists in tobacco cessation
31 May 2023Tobacco use is a global health problem with 1.13 billion smokers and 8 million deaths annually, including 1.2 million from second-hand smoke. It is a burden on individuals, communities and economies, causing various diseases and preventable deaths.
Tobacco is a major risk factor for non-communicable diseases such as chronic respiratory and cardiovascular diseases, cancer and diabetes. At this event, FIP will launch a new handbook to support pharmacists and their organisations in providing a range of tobacco cessation services. This will be accompanied by a reference guide identifying the knowledge and skills pharmacists need to provide such services.
